Seegene novaplex

Ended Purchase Order Awarded

Contract number
75D30122P15718
Awardee
Awarding agency
Obligated
$72,000

Award facts

Contract value 100% obligated
$72,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Walnut Creek, CA 94598, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $72,000 firm-fixed-price purchase order to Seegene USA Inc. Sales Division, a foreign-owned for-profit small business, for the provision of SEEGENE NOVAPLEX molecular diagnostic reagents and associated products. This award supports the CDC's public health mission related to advancement of human papillomavirus (HPV) screening and prevention. The contract does not have a set-aside designation and there are no subcontractors involved. Seegene USA Inc. has previously provided HPV detection assay kits, reagents, and Novaplex II HPV28 detection kits to the CDC's Pittsburgh location through prior contract awards in 2019-2021.

Quick answers

Who was awarded contract 75D30122P15718?

75D30122P15718 was awarded to Seegene Usa, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 23, 2022.

How much is contract 75D30122P15718 worth?

The government has obligated $72,000 on 75D30122P15718.

Was contract 75D30122P15718 competed?

The extent of competition for 75D30122P15718 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award